Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Huland

Showing results (61-70 of 314) with videos related to

Pageof 32
Sort By:
Der Urologe. Ausg. A|March 1, 1990
[Tumor markers and prognostic parameters in urinary bladder cancer]A W Schneider, H Huland
Zeitschrift Fur Urologie Und Nephrologie|January 1, 1980
[Effect of dopamine on renal and intrarenal hemodynamics in unilateral ureteral occlusion]H J Augustin, H Huland
Der Urologe. Ausg. A|July 23, 2002
[Regional immunotherapy of metastatic renal cell carcinoma]H Heinzer, E Huland, H Huland
Folia Biologica|January 5, 2001
A comparison of systemic versus inhaled recombinant IL-2 administration for the treatment of metastatic renal cell carcinomaE Huland, H Heinzer, H Huland
The Journal of Urology|April 21, 1999
The role of C-reactive protein in graft dysfunction after renal transplantationC Reek, S Conrad, H Huland
Monatsschrift Kinderheilkunde : Organ Der Deutschen Gesellschaft Fur Kinderheilkunde|November 1, 1982
[Sonography for monitoring kidney transplants]T Riebel, H Altrogge, H Huland
European Urology|January 1, 1995
Autologous blood transfusion in radical prostatectomy: results in 263 patientsJ Noldus, D Gonnermann, H Huland
Journal of Cancer Research and Clinical Oncology|January 1, 1994
Inhaled interleukin-2 in combination with low-dose systemic interleukin-2 and interferon alpha in patients with pulmonary metastatic renal-cell carcinoma: effectiveness and toxicity of mainly local treatmentE Huland, H Heinzer, H Huland
European Urology|January 1, 1991
Complicated urinary tract infectionsS Conrad, R Busch, H Huland
Der Urologe. Ausg. A|November 18, 2015
[Systematic analysis of treatment results as a quality control instrument using the example of a large European center]B Beyer, H Huland, M Graefen
Pageof 32

Showing results (61-70 of 314) with videos related to

Sort By:
Pageof 32
Der Urologe. Ausg. A|March 1, 1990
[Tumor markers and prognostic parameters in urinary bladder cancer]A W Schneider, H Huland
Zeitschrift Fur Urologie Und Nephrologie|January 1, 1980
[Effect of dopamine on renal and intrarenal hemodynamics in unilateral ureteral occlusion]H J Augustin, H Huland
Der Urologe. Ausg. A|July 23, 2002
[Regional immunotherapy of metastatic renal cell carcinoma]H Heinzer, E Huland, H Huland
Folia Biologica|January 5, 2001
A comparison of systemic versus inhaled recombinant IL-2 administration for the treatment of metastatic renal cell carcinomaE Huland, H Heinzer, H Huland
The Journal of Urology|April 21, 1999
The role of C-reactive protein in graft dysfunction after renal transplantationC Reek, S Conrad, H Huland
Monatsschrift Kinderheilkunde : Organ Der Deutschen Gesellschaft Fur Kinderheilkunde|November 1, 1982
[Sonography for monitoring kidney transplants]T Riebel, H Altrogge, H Huland
European Urology|January 1, 1995
Autologous blood transfusion in radical prostatectomy: results in 263 patientsJ Noldus, D Gonnermann, H Huland
Journal of Cancer Research and Clinical Oncology|January 1, 1994
Inhaled interleukin-2 in combination with low-dose systemic interleukin-2 and interferon alpha in patients with pulmonary metastatic renal-cell carcinoma: effectiveness and toxicity of mainly local treatmentE Huland, H Heinzer, H Huland
European Urology|January 1, 1991
Complicated urinary tract infectionsS Conrad, R Busch, H Huland
Der Urologe. Ausg. A|November 18, 2015
[Systematic analysis of treatment results as a quality control instrument using the example of a large European center]B Beyer, H Huland, M Graefen
Pageof 32